Primary endpoint of 5 phase III randomized trials will be presented during
@myESMO
2020, including 1st ADC in TNBC and 1st adjuvant trials testing cdk4/6 inh.
🚨Less then 🔟days before the start of virtual
#ESMO20
and 2⃣weeks before the start of the science weekend, besides looking forward to our
#YoungOncologistCommittee
track, i'm eagerly awaiting so many new exciting data in
#breastcancer
My top 10 selection🤗 👇
@OncoAlert
@myESMO
1
40
84
1
37
98